Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 21, 2002
The value of PSA measurements at 30 Gy, 50 Gy and 60 Gy for dose limitation in patients with radiotherapy for PSA increase after radical prostatectomy
Thomas Wiegel, Dirk Bottke, Patrick Bandlow, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS
|
August 5, 2011
Novel low-cost prostate resection trainer-description and preliminary evaluation
Jan Ebbing, Martin Schostak, Ursula Steiner, et al.
Oncology
|
March 27, 2009
Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib
Kaja Zimmermann, Alexander Schmittel, Ursula Steiner, et al.
Journal of Clinical Medicine
|
July 13, 2019
Outcome of Photoselective Vaporization of the Prostate with the GreenLight-XPS 180 Watt System Compared to Transurethral Resection of the Prostate
Maximilian Reimann, Nikita Fishman, Isabel Lichy, et al.
BJU International
|
April 11, 2018
Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE)
Hannes Cash, Ursula Steiner, Axel Heidenreich, et al.
Urologia Internationalis
|
April 6, 2018
Perioperative Changes and Progress in Photoselective Vaporization of the Prostate with GreenLight XPS 180 W System: A Single Center Experience
Maximilian Reimann, Nikita Fishman, Zenai Almedom, et al.
BMC Medical Informatics and Decision Making
|
August 7, 2013
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin
Daniel Baumunk, Roman Reunkoff, Julien Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2009
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel, Dirk Bottke, Ursula Steiner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 3, 2014
Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial
Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, et al.
European Urology
|
November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme
Axel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 21, 2002
The value of PSA measurements at 30 Gy, 50 Gy and 60 Gy for dose limitation in patients with radiotherapy for PSA increase after radical prostatectomy
Thomas Wiegel, Dirk Bottke, Patrick Bandlow, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS
|
August 5, 2011
Novel low-cost prostate resection trainer-description and preliminary evaluation
Jan Ebbing, Martin Schostak, Ursula Steiner, et al.
Oncology
|
March 27, 2009
Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib
Kaja Zimmermann, Alexander Schmittel, Ursula Steiner, et al.
Journal of Clinical Medicine
|
July 13, 2019
Outcome of Photoselective Vaporization of the Prostate with the GreenLight-XPS 180 Watt System Compared to Transurethral Resection of the Prostate
Maximilian Reimann, Nikita Fishman, Isabel Lichy, et al.
BJU International
|
April 11, 2018
Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE)
Hannes Cash, Ursula Steiner, Axel Heidenreich, et al.
Urologia Internationalis
|
April 6, 2018
Perioperative Changes and Progress in Photoselective Vaporization of the Prostate with GreenLight XPS 180 W System: A Single Center Experience
Maximilian Reimann, Nikita Fishman, Zenai Almedom, et al.
BMC Medical Informatics and Decision Making
|
August 7, 2013
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin
Daniel Baumunk, Roman Reunkoff, Julien Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2009
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel, Dirk Bottke, Ursula Steiner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 3, 2014
Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial
Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, et al.
European Urology
|
November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme
Axel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
Page
of 2